Professor Cass Byrnes discusses the treatment of cystic fibrosis patients with a CFTR modulator, and the evidence for the use of Trikafta

Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) is funded for people aged 6 years and above with cystic fibrosis (CF), subject to eligibility criteria.

Professor Cass Byrnes MBChB, FRACP, MD (Auckland), GCCE (New South Wales) is in the Paediatric Department of the University of Auckland and a Paediatric Respiratory Specialist at Starship Children's Health and Kidz First Hospital.

Extended Prevention of Recurrent VTE

Speaker: Dr Gordon Royle

In this recording of a live webcast event held in August 2020, Dr Royle addressed an audience of GPs and nurse practitioners on extended prevention of recurrent venous thromboembolism in primary care with a focus on the recommendations in the THANZ 2019 VTE Guidelines.

Gordon Royle is a graduate of Otago Medical School. After moving to Auckland he undertook a Masters in Molecular Biology, and went on to train in Haematology. For the last 19 years he has been working as a Haematologist and researcher at Middlemore Hospital, and is a senior lecturer at Auckland University's School of Medicine. A particular interest is Coagulation Haematology. His clinical research experience includes the role of PI in several new oral anticoagulant trials. Prior research experience includes seven years' molecular biology in the USA including two years at The Salk Institute.

GORD – How to Optimise Management

Presented by Gastroenterologist Alasdair Patrick

Insulin initiation, titration and escalation: A practical guide for busy clinicians in primary care

Webinar - October 2019

Presentation by:
Carl Peters
Endocrinologist, North Shore Hospital

In this webinar, Dr Carl Peters provided clinicians with a practical guide to the use of insulin in patients with type 2 diabetes mellitus.

Breakfast Session - Shared Care of the IBD Patient

GPCME 2018 - Rotorua
Sunday June 10, 2018

Presentations by:
Drs Rick Stein and Ali Jafer (Consultant Gastroenterologists)
Phoebe Wu and Jacqui Fletcher (IBD Nurses)

In this Breakfast Session held at GPCME 2018, Dr Rick Stein discussed the growing burden of IBD in NZ.

Dr Ali Jafer and Phoebe Wu also presented on the value of and models for shared care for the IBD patient, and Jacqui Fletcher gave tips for primary care clinicians on the best approaches to managing IBD patients.

The video production for this presentation was funded by Emerge Health.

IBD in Primary Care – Practical Management Tips

GPCME 2018 - Rotorua
Saturday June 9, 2018

Presentation by:
Dr David Rowbotham
Consultant Gastroenterologist, Department of Gastroenterology and Hepatology, Auckland Hospital

In this workshop held at GPCME 2018, Dr David Rowbotham presented tips for primary care clinicians on the best approaches to managing IBD patients in everyday practice. He also discussed some novel therapies, stopping treatment and the IBD clinical trials taking place at the Auckland District Health Board.

The video production for this presentation was funded by Emerge Health.

The importance of using tools beyond lifestyle in managing obesity

Goodfellow Symposium
Sunday 25 March 2018

Presentation by:

Professor John Dixon, Head of clinical obesity research at the Baker Heart and Diabetes Institute in Melbourne, Australia.

In this Breakfast Symposium, Professor John Dixon focused on the importance of tools such as pharmacotherapy, meal replacements and bariatric surgery, as lifestyle enablers, in the management of obesity, a disease he notes should be approached in the same manner as other chronic illnesses.